GO:0035592 establishment of protein localization to extracellular region: Secretory Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0035592 describes the directed movement of a protein to a specific location within the extracellular region, a process essential for intercellular communication and tissue homeostasis.
This process includes the classical secretory pathway (ER to Golgi to plasma membrane) and unconventional secretion mechanisms that bypass the Golgi.
Key protein families involved include G-protein coupled receptors (GPCRs), extracellular matrix proteins such as FBLN7, and signaling molecules like EMP1.
Dysregulation of protein localization to the extracellular region is linked to hypertension, fibrosis, cancer progression, and developmental disorders.
CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the molecular machinery and disease relevance of this process.
Understanding GO:0035592 provides insights into biomarker discovery, therapeutic target identification, and fundamental cell biology.

Description

The establishment of protein localization to the extracellular region (GO:0035592) is a fundamental biological process that ensures proteins are delivered to their correct destinations outside the cell. This process is critical for a myriad of physiological functions, including cell-cell signaling, immune response, and tissue remodeling. Proteins destined for the extracellular space must navigate a complex series of intracellular compartments and transport mechanisms, and defects in this pathway can lead to a wide range of diseases. Researchers studying this process aim to understand the molecular machinery, regulatory signals, and cargo-specific sorting that govern extracellular protein localization. Recent advances in CRISPR gene editing and high-throughput screening have accelerated the discovery of genes and pathways controlling this process, offering new opportunities for therapeutic intervention.

establishment of protein localization to extracellular region At A Glance

GO ID GO:0035592
GO term establishment of protein localization to extracellular region
Ontology biological_process
Synonym establishment of protein localisation in extracellular region; establishment of protein localization in extracellular region
Major function Directed movement of proteins to the extracellular region
Related processes Protein secretion, extracellular matrix assembly, cell signaling
Cellular locations Endoplasmic reticulum, Golgi apparatus, secretory vesicles, plasma membrane, extracellular space
Key regulators GTPases, SNAREs, coat proteins, glycosylation enzymes
Disease relevance Hypertension, fibrosis, cancer, developmental disorders

What Is GO:0035592?

According to the Gene Ontology, GO:0035592 is defined as the directed movement of a protein to a specific location within the extracellular region. This encompasses all steps required for a protein to reach and be positioned in the extracellular space, including synthesis, folding, trafficking through the secretory pathway, and final deposition or secretion.

Why Is establishment of protein localization to extracellular region Important in Cell Biology?

The establishment of protein localization to the extracellular region is vital for normal physiology and is implicated in numerous diseases. For example, FBLN7, an extracellular matrix protein, mediates vascular smooth muscle cell phenotype switching and vascular remodeling in hypertension. Similarly, EMP1+ hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma, highlighting the role of extracellular protein localization in cancer. Understanding this process is therefore essential for developing diagnostics and therapeutics targeting a wide range of conditions.
Enables cell-cell communication through secreted signaling molecules such as hormones and cytokines.
Facilitates tissue remodeling and repair by delivering extracellular matrix components.
Supports immune surveillance by localizing antibodies and immune modulators to the extracellular space.
Dysregulation leads to fibrosis, as seen in hepatic stellate cell-driven liver disease.
Contributes to cancer progression through secretion of growth factors and matrix metalloproteinases.
Plays a role in hypertension via vascular smooth muscle cell phenotype switching.
Is essential for normal development, as defects cause congenital disorders.
Provides targets for therapeutic intervention in diseases like rhabdomyolysis.
Underpins the mechanism of action of many biologics and recombinant protein drugs.
Offers opportunities for biomarker discovery in extracellular fluids.

What Happens During establishment of protein localization to extracellular region?

Protein Synthesis and Translocation into the Endoplasmic Reticulum
In simple terms: Proteins destined for outside the cell are first made and fed into the ER.
Proteins destined for the extracellular region typically contain a signal peptide that directs them to the endoplasmic reticulum (ER) during translation. This process involves the signal recognition particle (SRP) and the translocon complex, allowing the nascent polypeptide to enter the ER lumen or membrane. Once in the ER, proteins undergo folding and initial post-translational modifications such as N-glycosylation, which are critical for their subsequent trafficking.
Vesicular Transport from ER to Golgi
In simple terms: Proteins are packaged into vesicles and shipped from the ER to the Golgi.
After folding, proteins are packaged into COPII-coated vesicles that bud from the ER and fuse with the Golgi apparatus. This step is regulated by small GTPases such as Sar1 and Rab proteins, and ensures that only properly folded proteins proceed. The Golgi further modifies proteins, including glycosylation and proteolytic processing, before they are sorted to their final destinations.
Sorting at the Trans-Golgi Network
In simple terms: The Golgi acts as a post office, sorting proteins to different destinations.
At the trans-Golgi network (TGN), proteins are sorted into distinct vesicles destined for the plasma membrane, secretory granules, or other compartments. Sorting signals within the protein sequence or attached glycans direct this process. For example, GPCRs are sorted to the cell surface where they can respond to extracellular ligands. Defects in sorting can lead to mislocalization and disease.
Fusion with the Plasma Membrane and Release
In simple terms: Vesicles fuse with the cell membrane, releasing proteins outside.
Secretory vesicles fuse with the plasma membrane in a process mediated by SNARE proteins and calcium signaling. This releases the protein cargo into the extracellular space, either constitutively or in response to stimuli. For instance, class B1 GPCRs are delivered to the cell surface where their extracellular domains modulate signaling. This step is also crucial for the release of extracellular matrix proteins like FBLN7.
Unconventional Secretion Pathways
In simple terms: Some proteins bypass the Golgi to get outside the cell.
Not all extracellular proteins follow the classical ER-Golgi route. Unconventional secretion mechanisms, such as direct translocation across the plasma membrane or secretion via extracellular vesicles, exist for proteins lacking signal peptides. These pathways are less understood but are implicated in immune responses and cancer. Research into these mechanisms is an active area of cell biology.

Key Genes Involved in GO:0035592 establishment of protein localization to extracellular region

The following genes and proteins are key players in the establishment of protein localization to the extracellular region, based on published literature.
GeneMajor RoleResearch Relevance
FBLN7Extracellular matrix protein; mediates vascular smooth muscle cell phenotype switchingHypertension and vascular remodeling
EMP1Epithelial membrane protein 1; drives hepatic fibrosis to hepatocellular carcinomaLiver fibrosis and cancer
GNASG-protein subunit alpha s; involved in GPCR signalingClass B1 GPCR signaling
ADRB2Beta-2 adrenergic receptor; model GPCRGPCR trafficking and signaling
INSInsulin; secreted hormoneDiabetes and metabolic disorders
ALBAlbumin; major plasma proteinLiver function and rhabdomyolysis
COL1A1Collagen type I alpha 1; extracellular matrix componentFibrosis and tissue remodeling
MMP9Matrix metalloproteinase 9; degrades extracellular matrixCancer invasion and metastasis
TGFB1Transforming growth factor beta 1; secreted cytokineFibrosis and cancer
VEGFAVascular endothelial growth factor A; secreted angiogenic factorAngiogenesis and cancer
IL6Interleukin 6; secreted cytokineInflammation and immune response
TNFTumor necrosis factor; secreted cytokineInflammation and cancer
WNT3AWnt family member 3A; secreted signaling moleculeDevelopment and cancer
SHHSonic hedgehog; secreted morphogenDevelopment and cancer
BMP4Bone morphogenetic protein 4; secreted growth factorDevelopment and fibrosis
NOTCH1Notch receptor 1; cell surface receptorCell fate and cancer
CDH1E-cadherin; cell adhesion moleculeEpithelial-mesenchymal transition

How Is establishment of protein localization to extracellular region Regulated?

The establishment of protein localization to the extracellular region is tightly regulated at multiple levels. Transcriptional control determines the abundance of secreted proteins, while post-translational modifications such as glycosylation and phosphorylation influence trafficking and stability. Signaling pathways, including mTOR and the unfolded protein response (UPR), modulate the secretory capacity of cells in response to stress and nutrient availability. Additionally, small GTPases of the Rab and Arf families act as molecular switches to ensure fidelity of vesicle transport. Dysregulation of these regulatory mechanisms can lead to diseases such as fibrosis and cancer.

establishment of protein localization to extracellular region and Human Disease

GeneDisease / BiologyPotential Experimental Model
FBLN7Hypertension, vascular remodelingKnockout mouse or rat model; vascular smooth muscle cells
EMP1Liver fibrosis, hepatocellular carcinomaKnockout or overexpression in hepatic stellate cells; liver organoids
ALBRhabdomyolysis, liver functionKnockout hepatocytes; serum albumin measurement
WNT3ADevelopmental disorders, cancerKnockout or knock-in in embryonic stem cells; organoids
INSDiabetesKnockout pancreatic beta cells; insulin secretion assays
Hypertension and Vascular Remodeling
FBLN7, an extracellular matrix protein, mediates vascular smooth muscle cell phenotype switching and vascular remodeling in hypertension. Knockdown of FBLN7 alters the secretion of matrix proteins, highlighting the role of GO:0035592 in vascular disease.
Liver Fibrosis and Hepatocellular Carcinoma
EMP1+ hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma. These cells secrete extracellular matrix components and signaling molecules that promote fibrosis and tumorigenesis, underscoring the importance of protein localization to the extracellular region in liver disease.
Rhabdomyolysis and Muscle Damage
Rhabdomyolysis involves the breakdown of muscle tissue and release of intracellular proteins into the extracellular space. While this is a pathological release, it highlights the importance of proper protein localization for muscle function and the consequences of its failure.
Developmental Disorders
Proper localization of signaling molecules such as Wnt, Hedgehog, and BMP is essential for embryonic development. Disruption of these pathways due to defective secretion can lead to congenital malformations and developmental disorders.

From establishment of protein localization to extracellular region-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the role of FBLN7 in vascular remodeling?FBLN7 knockout mouse or rat; primary vascular smooth muscle cells
How does EMP1 contribute to liver fibrosis?EMP1 knockout or overexpression in hepatic stellate cells; liver organoids
What is the function of a specific secretory signal peptide?Point mutations in the signal peptide sequence; tagged knock-in for imaging
How does glycosylation affect protein secretion?Knockout of glycosyltransferases; point mutations at glycosylation sites
What genes regulate extracellular protein localization?Genome-wide CRISPR knockout library screening
Can we visualize protein secretion in real-time?Tagged knock-in of secreted proteins with fluorescent proteins; live-cell imaging

How to Study the establishment of protein localization to extracellular region Process

MethodWhat It MeasuresTypical Application
CRISPR knockout screeningLoss-of-function phenotypes for all genesIdentify regulators of protein secretion
Proteomics (secretome)Abundance of secreted proteinsDiscover biomarkers in disease
Live-cell imagingReal-time trafficking of tagged proteinsStudy secretion dynamics
RNA-seqTranscriptional changesIdentify pathways affecting secretion
Western blotProtein levels in cell lysates and mediaValidate secretion defects
ELISAQuantification of specific secreted proteinsMeasure cytokine or hormone release
Organoid culture3D tissue-like structuresModel epithelial secretion and disease
Bioinformatics pathway analysisEnrichment of GO terms and pathwaysInterpret omics data in context of GO:0035592
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate the establishment of protein localization to the extracellular region. For example, a screen for regulators of GPCR surface expression could reveal novel trafficking factors.
Proteomics and Secretome Analysis
Mass spectrometry-based proteomics of conditioned media can quantify secreted proteins and identify changes in extracellular protein localization under different conditions. This approach is useful for biomarker discovery and understanding disease mechanisms.
Live-Cell Imaging
Tagging proteins with fluorescent markers allows real-time visualization of their trafficking from the ER to the extracellular space. This method can reveal the dynamics of secretion and the effects of mutations.
Transcriptomics and Bioinformatics
RNA-seq and bioinformatics analyses can identify gene expression changes associated with altered extracellular protein localization. Pathway enrichment analysis can highlight relevant GO terms and regulatory networks.

How CRISPR Can Be Used to Study GO:0035592 establishment of protein localization to extracellular region

Knockout

CRISPR knockout of genes involved in protein localization to the extracellular region can reveal their essential functions. For example, knocking out FBLN7 in vascular smooth muscle cells alters their phenotype and matrix secretion, providing insights into hypertension. Similarly, knockout of EMP1 in hepatic stellate cells can reduce fibrosis progression.

Point Mutation

Introducing point mutations in genes encoding secreted proteins or trafficking machinery can dissect specific domains or residues required for extracellular localization. For instance, mutating glycosylation sites in a secreted protein can test their role in folding and secretion. Point mutations in GPCRs can affect their surface expression and signaling.

Knock-in

Knock-in of tags or reporters allows visualization and tracking of proteins destined for the extracellular space. Tagging endogenous albumin with a fluorescent protein enables real-time imaging of secretion in hepatocytes. Knock-in of disease-associated mutations can model human disorders.

Overexpression

Overexpression of secreted proteins or their regulators can mimic pathological states such as fibrosis or cancer. Overexpressing TGFB1 in liver cells promotes fibrosis and extracellular matrix deposition. Overexpression of WNT3A can activate developmental pathways.

How EDITGENE Supports establishment of protein localization to extracellular region Research

Researchers studying establishment of protein localization to extracellular region-related genes often need to determine whether a candidate gene is causally involved in a specific disease or cellular process. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for establishment of protein localization to extracellular region research.

Frequently Asked Questions About establishment of protein localization to extracellular region

GO:0035592 is the Gene Ontology term for the establishment of protein localization to the extracellular region, describing the directed movement of proteins to specific locations outside the cell.
Key genes include FBLN7, EMP1, GNAS, ADRB2, INS, ALB, COL1A1, MMP9, TGFB1, VEGFA, IL6, TNF, WNT3A, SHH, BMP4, NOTCH1, and CDH1, among many others.
It is regulated by transcriptional control, post-translational modifications, signaling pathways such as mTOR and UPR, and small GTPases that control vesicle trafficking.
Diseases include hypertension, liver fibrosis, hepatocellular carcinoma, rhabdomyolysis, and developmental disorders.
Common methods include CRISPR screening, proteomics, live-cell imaging, RNA-seq, Western blot, ELISA, and organoid culture.
CRISPR can create knockout, point mutation, knock-in, and overexpression models to dissect gene function and visualize protein trafficking.
FBLN7 is an extracellular matrix protein that mediates vascular smooth muscle cell phenotype switching and vascular remodeling in hypertension.
EMP1+ hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma, involving secretion of extracellular matrix and signaling molecules.
Unconventional secretion refers to protein export pathways that bypass the classical ER-Golgi route, such as direct translocation or extracellular vesicles.
Glycosylation affects protein folding, stability, and trafficking, and is often required for efficient secretion to the extracellular region.

Conclusion

The establishment of protein localization to the extracellular region (GO:0035592) is a cornerstone of cell biology, enabling communication, tissue organization, and immune defense. Dysregulation of this process contributes to a spectrum of diseases, from hypertension to cancer. Advances in CRISPR technology and high-throughput screening are providing unprecedented insights into the molecular players and regulatory networks involved. EDITGENE's comprehensive services empower researchers to dissect these mechanisms and accelerate the development of targeted therapies.

References

  1. 1. Herman TF et al.. 2026. Mu Receptors.. PMID: 31855381
  2. 2. Rout P et al.. 2026. Rhabdomyolysis.. PMID: 28846335
  3. 3. Yao G et al.. 2024. FBLN7 mediates vascular smooth muscle cell phenotype switching and vascular remodeling in hypertension.. Theranostics 14(19):7569-7588 PMID: 39659565
  4. 4. Zamudio AV et al.. 2019. Mediator Condensates Localize Signaling Factors to Key Cell Identity Genes.. Mol Cell 76(5):753-766.e6 PMID: 31563432
  5. 5. White AD et al.. 2026. Extracellular domain-dependent modulation of class B1 G-protein-coupled receptor signaling.. Mol Pharmacol 108(4):100111 PMID: 41795246
  6. 6. Tang X et al.. 2026. Nuclear N-glycosylation maintains H3K9me3 heterochromatin and genomic stability.. Nat Cell Biol 28(6):1269-1280 PMID: 42050147
  7. 7. Yoneda T et al.. 2026. Establishment of a Novel Human Endometrial Organoid.. Reprod Med Biol 25(1):e70030 PMID: 41710599
  8. 8. You J et al.. 2025. EMP1 + hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma and predict prognosis.. J Transl Med 24(1):29 PMID: 41327189
Contact Us
*
*
*
*
How did you hear about us: